Perspective Therapeutics
Price & Volume
Stats
See more52W Range | $1.60-$13.19 |
Market Cap | $257.6M |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $1.2M |
Revenue Growth (YoY) | -44.9% |
Gross Profit (12 Mos) | -$51M |
Diluted EPS | -$1.37 |
News
See moreYahoo Finance • 25 days ago
Perspective Therapeutics Progresses Dose Finding for [212Pb]VMT01 in Combination with Nivolumab in its Ongoing Phase 1/2a Study of MC1R-Positive Metastatic Melanoma
Yahoo Finance • last month
Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors
Yahoo Finance • last month
Perspective Therapeutics to Participate in Upcoming September Conferences
Yahoo Finance • 2 months ago
PERSPECTIVE THERAPEUTICS INC (NYSEARCA:CATX) Surpasses Q2 2025 Revenue Estimates with Narrower Loss
About
CEO | Mr. Johan M. Spoor |
Address | 2401 Elliott Avenue, Seattle, WA, United States, 98121 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 138 |
